These final results, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the notion of targeting ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant disorders. We independently study, overview, and https://peterz001vmd8.gynoblog.com/profile